Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Vascular and Mixed Dementia
NCT00174382Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jun 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in vascular dementia, mixed dementia, sponsored by Pfizer. Started Jun 2005; status: terminated.
02
Drugs
donepezil
03
Conditions
vascular dementiamixed dementia
Beyond the preview
Go deeper on NCT00174382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174382.